Regenerative Therapies Market, By Tissue Type (Allograft, Xenograft, Alloplast), By Application (Soft Tissue Repair, Cardiovascular, Dental, Orthopedic, CNS disease treatment, Others), By End User (Hospitals, Ambulatory Surgical Centers, Educational Insti

Regenerative Therapies Market, By Tissue Type (Allograft, Xenograft, Alloplast), By Application (Soft Tissue Repair, Cardiovascular, Dental, Orthopedic, CNS disease treatment, Others), By End User (Hospitals, Ambulatory Surgical Centers, Educational Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study:

This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global regenerative therapies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Nuo Therapeutics (Cytomedix Inc.), Advanced Cell Technology, Inc., BioStem Life Sciences, Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., and Cytori Therapeutics, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Regenerative Therapies Market, By Tissue Type:
Allograft
Xenograft
Alloplast
Global Regenerative Therapies Market, By Application:
Soft Tissue Repair
Cardiovascular
Dental
Orthopedic
CNS disease treatment
Others
Global Regenerative Therapies Market, By End User:
Hospitals
Ambulatory Surgical Centers
Educational Institutes
Global Regenerative Therapies Market, By Geography:
North America
By Tissue Type
Allograft
Xenograft
Alloplast
By Application
Soft Tissue Repair
Cardiovascular
Dental
Orthopedic
CNS disease treatment
Others
By End User
Hospitals
Ambulatory Surgical Centers
Educational Institutes
By Country:
U.S.
Canada
Europe
By Tissue Type
Allograft
Xenograft
Alloplast
By Application
Soft Tissue Repair
Cardiovascular
Dental
Orthopedic
CNS disease treatment
Others
By End User
Hospitals
Ambulatory Surgical Centers
Educational Institutes
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Tissue Type
Allograft
Xenograft
Alloplast
By Application
Soft Tissue Repair
Cardiovascular
Dental
Orthopedic
CNS disease treatment
Others
By End User
Hospitals
Ambulatory Surgical Centers
Educational Institutes
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Tissue Type
Allograft
Xenograft
Alloplast
By Application
Soft Tissue Repair
Cardiovascular
Dental
Orthopedic
CNS disease treatment
Others
By End User
Hospitals
Ambulatory Surgical Centers
Educational Institutes
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Tissue Type
Allograft
Xenograft
Alloplast
By Application
Soft Tissue Repair
Cardiovascular
Dental
Orthopedic
CNS disease treatment
Others
By End User
Hospitals
Ambulatory Surgical Centers
Educational Institutes
By Country:
GCC
Israel
Rest of Middle East
Africa
By Tissue Type
Allograft
Xenograft
Alloplast
By Application
Soft Tissue Repair
Cardiovascular
Dental
Orthopedic
CNS disease treatment
Others
By End User
Hospitals
Ambulatory Surgical Centers
Educational Institutes
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Shire Pharmaceuticals *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Kinetic Concepts, Inc.
Mesoblast Ltd.
Nuo Therapeutics (Cytomedix Inc.)
Advanced Cell Technology, Inc.
BioStem Life Sciences
Akron Biotechnology, LLC
Organovo Holdings Inc.
Orgenesis Inc.
Pluristem Therapeutics Inc.
Genzyme
Athersys, Inc.
RenovaCare, Inc.
Cytori Therapeutics, Inc.

“*” marked represents similar segmentation in other categories in the respective section.